Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This study will assess whether co-administration of ezetimibe 10 mg with simvastatin 20 mg
will be more effective than treatment with simvastatin 20 mg alone in reducing LDL-C
concentrations when administered for 6 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin